Document Detail

Choroidal hemorrhage associated with systemic tissue plasminogen activator.
MedLine Citation:
PMID:  8610807     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To determine the cause of spontaneous choroidal hemorrhage in a 67-year-old man after a myocardial infarction and administration of tissue plasminogen activator. METHODS: The patient underwent ocular examination. RESULTS: The patient retained excellent visual acuity and the choroidal hemorrhage resolved completely within two months. CONCLUSION: The administration of tissue plasminogen activator was responsible for the large extent of hemorrhage and should be considered in the differential diagnosis of hemorrhagic choroidal detachment.
J A Khawly; P J Ferrone; D E Holck
Related Documents :
7561557 - Thrombolytic therapy in 1995.
1636587 - Assessment of reperfusion after thrombolytic therapy for myocardial infarction.
21190777 - Ultrasound study of the prevalence of plaque at the carina in lesions that affect the c...
11577257 - Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic the...
7464207 - Complete recovery of the heart following exposure to profound hypothermia.
6342837 - The göteborg metoprolol trial. effects on mortality and morbidity in acute myocardial ...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of ophthalmology     Volume:  121     ISSN:  0002-9394     ISO Abbreviation:  Am. J. Ophthalmol.     Publication Date:  1996 May 
Date Detail:
Created Date:  1996-05-24     Completed Date:  1996-05-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370500     Medline TA:  Am J Ophthalmol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  577-8     Citation Subset:  AIM; IM    
Department of Ophthalmology, Duke University Eye Center, NC 27710, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Choroid / ultrasonography
Choroid Diseases / chemically induced,  ultrasonography
Choroid Hemorrhage / chemically induced*,  physiopathology,  ultrasonography
Fundus Oculi
Myocardial Infarction / drug therapy
Plasminogen Activators / adverse effects*,  therapeutic use
Tissue Plasminogen Activator / adverse effects*,  therapeutic use
Visual Acuity
Reg. No./Substance:
EC 3.4.21.-/Plasminogen Activators; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Postoperative hypopyon after intravitreal bovine thrombin for macular hole surgery.
Next Document:  Uveal effusion syndrome associated with primary pulmonary hypertension and vomiting.